Early Detection of Cervical Cancer Can Start at Home

Translate to Spanish or other 102 languages!

anuary is Cervical Cancer Awareness Month. According to the CDC, about 13,000 women are diagnosed with cervical cancer in the United States every year. Image for illustration purposes
anuary is Cervical Cancer Awareness Month. According to the CDC, about 13,000 women are diagnosed with cervical cancer in the United States every year. Image for illustration purposes
- Advertisement -

CLEVELAND CLINIC – January is Cervical Cancer Awareness Month. According to the CDC, about 13,000 women are diagnosed with cervical cancer in the United States every year. 

But with early screenings, that number could go down. 

“What’s interesting about cervical cancer, unlike many cancers, cervix cancer has a very long pre-cancerous phase, which is why screening is very helpful,” said Robert DeBernardo, MD, gynecologic oncologist at Cleveland Clinic. 

- Advertisement -

Dr. DeBernardo said screening for cervical cancer typically includes getting a pap smear, which can be uncomfortable for some women. 

However, there may soon be another option available. 

The FDA recently approved an at-home test kit. 

It looks for the presence of  HPV, or human papillomavirus. 

- Advertisement -

Dr. DeBernardo explains that nearly all cervical cancer cases are driven by HPV.

If the results of the test came back negative, then the person would not need to get a pap smear. 

“This test is going to be approved only for women at no elevated risk. So, for instance, if  I’ve had a problem with my pap smear in the past, no good. If I am immunosuppressed because I had a kidney transplant, no good — or HIV. There are going to be people that this test is not really designed for, and they should be seeing the gynecologist regularly,” said Dr. DeBernardo.

The  U.S. Department of Health and Human Services also updated its cervical cancer screening guidelines to include the use of the at home test kit. 

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorder

The U.S. Food and Drug Administration today approved Mimrylo (rusfertide), a new treatment for adults with polycythemia vera, a rare blood disorder that causes the body to make too many red blood cells.

Pediatricians Urge Caution with AI Health Tools

It seems like people are using AI for everything these days, including seeking medical advice for their children, but is that actually a good idea?

Smart Strategies to Fight Childhood Obesity Today

As kids head back to school and new routines are established, pediatricians are warning of the long-term consequences of obesity.

FDA Approves First Oral Drug Indicated to Treat Dermatomyositis in Adults

Lisraya is the first FDA-approved oral treatment option for patients with dermatomyositis, addressing the high unmet need for this rare disease.
- Advertisement -